Doyle L. Arnold
Analyst · -- I know it's not a risk-weighting problem, but just from an equity perspective. I mean, I guess the broader question is, if you're not going to be reinvesting it, and some of it hopefully will remix into loans over time, is there anything that you can do to just maximize the capacity of the balance sheet, and how you're earning on it
Well, the phase-in period is relatively long, and the biggest single impact is one we've talked about, it's nothing new. It's been in the kind of the proposal, the Basel committee itself without, and that's the AOCI. As it -- and that's, by far, the biggest single impact in the change from Basel I rules to Basel III rules for us. And as we discussed, all the trends in -- that we're seeing in the CDO portfolio would suggest that the AOCI mark should moderate over the next few quarters and through the years during the phase-in period. So there's a lot that can happen between where we are now and the full phase-in rule with regard to that number. Similarly, the deferred tax asset that requires future profitability towards realization, which is much, much smaller than the AOCI mark rule gets smaller as basically as NOL carryforwards are used up. And as we remain profitable, that too should happen. With regard to, I guess, the other thing -- the next bigger ones and one of the newer ones is the change in the risk weightings on basically nonperforming loans. And as those continue to come down, the impact of that number should come down. The 2 that probably are subject to a little more management discretion are kind of what we do in the way with residential mortgages and with unfunded commitments. You certainly don't want to stop making commitments but it -- one might look at the pricing of those commitments that are under a year. And with regard to residential mortgage, we have some unique -- I wouldn't say they're unique, but we have some products here that we think are very conservatively underwritten that get caught up in the full amortization rules that get them into a higher risk weight bucket. We need to look at those products, and how we price of them or design them to see if with some tweaks, they're still good products that have less risk-weighted impact. But we haven't started to do that yet. It's too [indiscernible]. Is that helpful?
Steven A. Alexopoulos - JP Morgan Chase & Co, Research Division: Yes, that's actually really helpful. Maybe just a quick follow-up. Looking at the core loan yields down around 10 basis points quarter-over-quarter, given the competitive environment, is this the quarterly pressure we should be thinking about? And maybe can you talk about where your loans were added in the portfolio in the quarter?